|
⚲
|
| Keyboard |
| Aperture Ventures IV Management LLC | |
|---|---|
| Firm | Aperture Management LLC |
| Address | 645 Madison Avenue, 20th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aperture Management LLC | |||||
| Aperture Venture Partners IV LP | 021-251935 | Executive Officer | 24.2 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Conversion | 232,963 | ||
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Buy | 112,000 | $10.00 | 1,120,000 |
|
Trevi Therapeutics Inc TRVI
Series C Preferred Stock · derivative
|
2019-05-09 | Conversion | 2,054,795 | $0.00 |